Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	18,916	15,489	29,329	3,061	5,311	4,343	Upgrade
Market Cap Growth	-47.19%	-47.19%	858.12%	-42.37%	22.29%	43.10%	Upgrade
Enterprise Value	72,703	73,224	92,597	70,212	75,922	25,235	Upgrade
Last Close Price	7.23	5.92	11.21	1.17	2.03	1.66	Upgrade
Forward PE	-	3.18	3.18	3.18	3.18	3.18	Upgrade
PS Ratio	5.88	4.82	6.15	0.76	1.00	0.79	Upgrade
PB Ratio	-0.23	-0.19	-0.59	-0.27	0.26	0.14	Upgrade
P/TBV Ratio	-	-	-	-	0.33	0.16	Upgrade
P/FCF Ratio	-	-	226.09	1.24	-	-	Upgrade
P/OCF Ratio	-	-	194.30	1.22	-	-	Upgrade
PEG Ratio	-	0.19	0.19	0.19	0.19	0.19	Upgrade
EV/Sales Ratio	22.60	22.76	19.40	17.31	14.23	4.60	Upgrade
EV/FCF Ratio	-93.93	-	713.83	28.38	-	-	Upgrade
Debt / Equity Ratio	-0.90	-0.90	-1.49	-6.42	3.51	2.30	Upgrade
Debt / FCF Ratio	-	-	569.51	29.60	-	-	Upgrade
Asset Turnover	0.01	0.01	0.02	0.02	0.02	0.02	Upgrade
Inventory Turnover	0.05	0.05	0.06	0.02	0.03	0.03	Upgrade
Quick Ratio	0.04	0.04	0.07	0.09	0.10	0.10	Upgrade
Current Ratio	0.70	0.70	0.76	0.86	0.98	1.02	Upgrade
Return on Equity (ROE)	-	-	-	-695.73%	-40.15%	-41.50%	Upgrade
Return on Assets (ROA)	-1.02%	-1.02%	-1.81%	-0.08%	-0.09%	-0.25%	Upgrade
Return on Capital (ROIC)	-34.22%	-34.22%	-11.21%	-0.28%	-0.24%	-0.60%	Upgrade
Earnings Yield	-137.11%	-167.44%	-113.43%	-910.68%	-190.54%	-367.06%	Upgrade
FCF Yield	-4.09%	-5.00%	0.44%	80.81%	-3.57%	-9.19%	Upgrade
Buyback Yield / Dilution	-0.03%	-0.03%	-	-	-	0.00%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.